Trial Profile
The Effect of High-dose Remifentanil on the Reversal of Neuropathic Pain in Postherpetic Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Acronyms RemiHighDose PHZ
- 18 Nov 2016 Status changed from recruiting to completed.
- 22 Jun 2011 New trial record